Understanding the Predictor Factors of Response of Radiotherapy for Oligometastatic Bladder Cancer
Steven Seyedin, Professor
UC San Francisco
Applications for Spring 2025 are closed for this project.
For patients with limited metastatic (stage IV) bladder cancer, high dose, high precision radiation therapy known as stereotactic body radiation therapy (SBRT), to all sites of disease can improve cancer outcomes and extend the time to needing additional therapy. However which patients truly benefit from SBRT is unclear. This study will aim to collect data from our institution and others to answer this question.
Role: - Write a IRB protocol to allow for collection of data from multiple institutional sites and understand the importance of safe patient collection
- Generate template to collect data and understand how to gather data which can be analyzed
- Learn how to analyze data with statistical team
- Present results as local conferences and how to generate posters/powerpoints
Qualifications: - Preferred if plan is to go to medical school
- Prior retrospective research experience
- Must be able to attend scheduled lab meeting every other week
- RedCap experienced a plus
Hours: 6-8 hrs
Off-Campus Research Site: UCSF
Related website: https://www.ucsfhealth.org/providers/dr-steven-seyedin
Biological & Health Sciences